Abstract
This article explores the application of machine learning, specifically the XGBoost algorithm, for the early detection of Parkinson’s disease. Parkinson’s disease is a prevalent neurodegenerative condition that poses diagnostic challenges, particularly in its early stages. To address these challenges, a comprehensive dataset, including vocal frequency measurements, audio analyses, and demographic data, is employed. Data preprocessing techniques, including Min-Max scaling and Synthetic Minority Over-sampling Technique (SMOTE), are applied to prepare the dataset. The XGBoost model is then developed and fine-tuned to achieve an accuracy of approximately 93.33% in detecting Parkinson’s disease. The model exhibits high precision, recall, and F1-Score, making it a valuable tool for early disease detection in the healthcare domain. The study highlights the transformative potential of machine learning in improving patient outcomes and healthcare efficiency.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Email: dheiver.santos{at}gmail.com, Tel.: +55 51 98988-9898
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.